Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 3,3013,320 of 20,252 grants

Completed RESEARCH CENTERS
CF 1: Biospecimen Repository Core
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2023 – 2024

CF-1: Biospecimen Repository ABSTRACT The Biospecimen Repository Core (CF-1) is designed to provide support to the basic and translational research efforts of the SPORE. The CF-1 w...

Completed RESEARCH CENTERS
CF 2: Biostatistics and Bioinformatics Core
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2023 – 2024

Core 2: Biostatistics and Bioinformatics ABSTRACT The Biostatistics & Bioinformatics Core will support investigators of the Soft Tissue Sarcoma SPORE in the computational and s...

Completed RESEARCH CENTERS
Novel therapeutics development and mechanisms of therapeutic resistance in gastrointestinal stromal tumor (GIST)
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2023 – 2024

RP-1: Novel Therapeutics Development and Mechanisms of Therapeutic Resistance in GIST ABSTRACT Gastrointestinal stromal tumor (GIST) represents one of the most prevalent sarcoma su...

Completed RESEARCH CENTERS
Targeting Oncogenic Pathways in Genetically Complex Sarcomas
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2023 – 2024

RP-3: Targeting oncogenic pathways in genetically complex sarcomas ABSTRACT Our overall goal is to find effective targeted therapies for two of the most common and aggressive types...

Active NON-SBIR/STTR RPGS
Long-Term Trajectories of Accelerated Biological Aging and Functional Decline Associated with Breast Cancer and its Treatment
NATIONAL CANCER INSTITUTE Kaiser Foundation Research Institute United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT More than 3.8 million women living in the United States have a history of invasive breast cancer, a majority of whom are over age 65. With 15-year survival...

$6.23M
USD
Completed OTHER RESEARCH-RELATED
Identifying Inflammatory Mediators of Clonal Hematopoiesis
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2023 – 2024

PROJECT SUMMARY/ABSTRACT Clonal hematopoiesis (CH) is a common phenomenon defined as the presence of somatic mutations in hematopoietic stem and progenitor cells (HSPCs) and their...

$254.3K
USD
Completed NON SBIR/STTR CONTRACTS
HOSTING, MAINTENANCE AND PROFESSIONAL SERVICES FOR RAVE AND MEDIDATA RAVE INTEGRATED ANCILLARY SOFTWARE FOR NCI'S CANCER THERAPY EVALUATION PROGRAM (CTEP)
NATIONAL CANCER INSTITUTE Unknown United States 2023 – 2024

The Contractor shall provide the Parent IDIQ SOW Tasks (Task Areas) 1, 2, 3, 4, and 5 as further described below:a) Hosting (Task 2) and maintenance (Task 3) for Rave-Classic (or R...

$98.72M
USD
Active RESEARCH CENTERS
Kaposi Sarcoma in the Era of ART in Africa Program (KEAAP)
NATIONAL CANCER INSTITUTE Lsu Health Sciences Center United States 2023 – 2028

There are currently over 1.2 million people in Zambia and 1.7 million in Tanzania who are living with HIV/AIDS. Concomitant to the HIV epidemic, there is a high incidence of HIV/AI...

$9.26M
USD
Active RESEARCH CENTERS
Admin Core
NATIONAL CANCER INSTITUTE Lsu Health Sciences Center United States 2023 – 2028

A multi-institutional, international, and integrated endeavor, the “KS in the Era of ART in Africa Program (KEAAP)” will leverage the research and training expertise of collaborati...

Active RESEARCH CENTERS
Project 1
NATIONAL CANCER INSTITUTE Lsu Health Sciences Center United States 2023 – 2028

Despite more than a decade of implementing universal access to antiretroviral therapy (ART) in sub-Saharan Africa (SSA), Kaposi’s sarcoma (KS) remains the most common malignancy in...

Active TRAINING, INDIVIDUAL
Molecular mechanism of membrane association of Bruton's Tyrosine Kinase
NATIONAL CANCER INSTITUTE Yale University United States 2023 – 2026

PROJECT SUMMARY The adaptive immune system is driven by the B Cell receptor (BCR) pathway, which triggers B cell differentiation and proliferation in response to antigen binding. A...

$470.4K
USD
Active NON-SBIR/STTR RPGS
Identification of DCLK2-TBK1 signaling axis as a potential therapeutic target in kidney cancer
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2023 – 2028

Project Summary Clear cell renal cell carcinoma (ccRCC), which accounts for approximately 85% of all renal cancers, is resistant to a variety of cancer therapies and is highly leth...

$4.46M
USD
Active RESEARCH CENTERS
Cancer Prevention-Interception Against MGUS Progression
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2023 – 2027

Project Summary Monoclonal gammopathy of undetermined significance (MGUS) is a precancerous condition in which a person has moderately elevated levels of an abnormal immunoglobulin...

$10.78M
USD
Active RESEARCH CENTERS
Administrative Core
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2023 – 2027

Project Summary The Administrative Core at the Cancer Prevention-Interception against MGUS Progression (CAP-MGUS) Center will provide administrative, scientific, fiscal, and logist...

Active RESEARCH CENTERS
Prevention of MGUS Progression to MM by Modulating the Bone Marrow Microenvironment
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2023 – 2027

PROJECT SUMMARY The long-term objective of this work is to determine the functional role of the bone marrow microenvironment in regulating the plasma cell growth of monoclonal gamm...

Active RESEARCH CENTERS
Prevent IgM MGUS Progression by Targeting the Driver Mutation
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2023 – 2027

Prevent IgM MGUS Progression by Targeting the Driver Mutation Project Summary Patients with monoclonal gammopathy of undetermined significance of the IgM class (IgM MGUS) are at in...

Active OTHER RESEARCH-RELATED
Understanding initiation and progression of IPMNs in pancreatic cancer
NATIONAL CANCER INSTITUTE Drexel University United States 2023 – 2026

Project Abstract Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease with a dismal survival rate at just 10%, largely because most patients are diagnosed after the cancer h...

$1.94M
USD
Active TRAINING, INSTITUTIONAL
Dartmouth Training Program in Quantitative Cancer Research
NATIONAL CANCER INSTITUTE Dartmouth College United States 2023 – 2028

ABSTRACT Continued support is requested for a multidisciplinary Dartmouth Training Program in Quantitative Cancer Research (TQCR). The TQCR Program seeks to provide cross-training...

$2.12M
USD
Active NON-SBIR/STTR RPGS
Development of Ubiquitin-Independent Degraders
NATIONAL CANCER INSTITUTE University of Florida United States 2023 – 2028

Project Summary Degraders are chemical dimerizers that recruit a target protein (TP) to an E3 Ubiquitin (Ub) ligase. In favorable cases, this results in TP poly-Ubiquitylation and...

$8.26M
USD
Active NON-SBIR/STTR RPGS
Enhancer RNAs Boost MYC-Chromatin Interaction to Regulate Gene Expression and Tumorigenesis
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2023 – 2028

Enhancer RNAs Boost MYC-Chromatin Interaction to Regulate Gene Expression and Tumorigenesis Summary: Our long-term goal is to determine how MYC’s RNA binding function contributes t...

$4M
USD